Recent findings published in Nature reveal that Rb-driven transcription can actively limit the tumor-suppressive effects of the protein in breast cancer models, uncovering an unexpected CDK4/6 paradox.
Cell Culture and Experimental Conditions
Researchers utilized a range of established cell lines to map these molecular pathways, including MCF7 (HTB-22), ZR-75-1 (CRL-1500), CAMA-1 (HTB-21), MDA-MB-453 (HTB-131), and MDA-MB-231 (HTB-26) cells obtained from the American Type Culture Collection, according to details outlined in Nature. Additional ovarian cancer lines such as OVCAR-3 (HTB-161) and Kuramochi (JCRB0098) were also examined. Chandarlaparty. Cell lines were maintained in media such as RPMI-1640 or DMEM supplemented with 10% fetal bovine serum, 1× GlutaMAX, and 1% HEPES, kept at 37 °C in a 5% CO2 humidified incubator. Mycoplasma contamination checks were routinely performed via PCR, and identities were confirmed via STR fingerprinting.
In Vitro Drug Treatments and Assays
Experimental protocols involved specific pharmacological agents to test cellular responses. Abemaciclib methanesulfonate and palbociclib isethionate were purchased from MedChemExpress, while INX-315 was obtained from Incyclix Bio, as reported by Nature. Degraders and endocrine therapies such as fulvestrant and imlunestrant were sourced from Selleck Chemicals. In vitro tests typically utilized 500 nM of abemaciclib or palbociclib, 300 nM of INX-315, 5 nm of fulvestrant, and 40 nM of imlunestrant diluted in dimethyl sulfoxide. Cell cycle progression was evaluated using BrdU incorporation assays following two to four days of drug exposure depending on the specific cell line.
Genomic Profiling and Flow Cytometry
To analyze chromatin binding and transcriptional activity, scientists applied CUT&RUN methods following synchronized drug treatments. Flow cytometry analysis was conducted on a BD A3 Symphony instrument, capturing a minimum of 10,000 live cell events per sample, with data subsequently processed using FlowJo software, according to Nature. Dose matrix drug combination assays assessed synergy by fixing cells with paraformaldehyde and staining nuclei with DAPI and Hoechst 33342 stains, imaged via Thermo Fisher Cellomics platforms to evaluate quantitative cell counts and proliferation markers.
Keep reading